Ondelopran

DB12585InvestigationalSmall molecule

Ondelopran has been used in trials studying the treatment of Alcohol Dependence.

Mechanism: Pharmacologically active on Mu-type opioid receptor
Curator reviewed
Formula / weight: C₂₀H₂₄FN₃O₃ · 373.428 g/mol (avg)
Code names: LY-2196044

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyQWNDOCKIKKQJNN-UHFFFAOYSA-NSMILESNC(=O)C1=CC=C(OC2=C(F)C=C(CNCCC3CCOCC3)C=C2)N=C1

Targets

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

54Drug interactionsStructured to mechanism, not free text

2Clinical trialsPhase, status and sponsor resolved per trial

1ATC codeIncluding every combination product, plus 9 drug categories

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Ondelopran, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.